NCT01280656

A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)

Retrospective Study to Evaluate the Impact of Using Interferon (Pegylated or Not) in the Treatment of Patients With Chronic Hepatitis C in Brazil (DECISION)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 660 (actual)
• Sponsor: Hoffmann-La Roche · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This retrospective study will assess the sustained virologic response and the safety of two different interferons (pegylated or conventional) in patients with chronic hepatitis C. Data will be collected for 24 weeks.

Conditions

• Hepatitis C, Chronic

Interventions

Type	Name	Description
DRUG	Conventional Interferon	Conventional interferon according to the standard of care and aligned with the local prescription instructions
DRUG	Peginterferon Alfa-2a	Peginterferon alfa-2a according to the standard of care and aligned with the local prescription instructions
DRUG	Peginterferon Alfa-2b	Peginterferon alfa-2b according to the standard of care and aligned with the local prescription instructions
DRUG	Ribavirin	Ribavirin according to the standard of care and aligned with the local prescription instructions

Timeline

• Start date: 2010-01-01
• Primary completion: 2012-11-01
• Completion: 2013-06-01
• First posted: 2011-01-21
• Last updated: 2016-11-29
• Results posted: 2016-09-26

Locations

37 sites across 1 country: Brazil